← Back to Clinical Trials
Recruiting NCT06508255

NCT06508255 Time-restricted Eating and Cognition

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06508255
Status Recruiting
Phase
Sponsor German Institute of Human Nutrition
Condition Time Restricted Eating
Study Type INTERVENTIONAL
Enrollment 35 participants
Start Date 2024-05-17
Primary Completion 2025-03

Trial Parameters

Condition Time Restricted Eating
Sponsor German Institute of Human Nutrition
Study Type INTERVENTIONAL
Phase N/A
Enrollment 35
Sex FEMALE
Min Age 18 Years
Max Age 70 Years
Start Date 2024-05-17
Completion 2025-03
Interventions
Early Time-Restricted EatingLate Time-Restricted Eating

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aims to investigate how time-restricted eating (TRE), more specifically TRE at different times (early vs late in the day), influences brain activity, behavior, decision-making, food intake, physical activity, the gut microbiome and metabolic processes. The study intervention procedure is a replication of that described in Peters et al. (2021).

Eligibility Criteria

Inclusion Criteria: * right-handed * legally competent * physically and mentally healthy * BMI: 19-35 kg/m² * fluent in reading and speaking German Exclusion Criteria: * weight change \>5% of body weight during the last 3 months * pregnancy or breastfeeding * allergies (inclusion possible after consultation with study doctor) * history of cardiovascular disease (myocardial infarction, stroke, hypertension, hypotension) in the last year * severe psychiatric condition, including drug addiction and depression * impaired renal or liver function * dementia or other severely debilitating cognitive disease * history of or current eating disorders (e.g., Bulimia nervosa, Anorexia nervosa, Orthorexia nervosa, Binge-Eating disorder) * chronic diseases (e.g., Morbus Crohn, Colitis Ulcerosa) * metabolic disorders (e.g., metabolic syndrome, diabetes type 1 or 2) * hormonal imbalances (e.g., thyroid gland diseases) * consuming diseases (e.g., cancer, kachexie) in the last 2 years * surgical removal

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology